4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-003985
Co-Chief Executive Officer sold 5,841 shares at $16.33 ($95,372)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2024-01-09 | Sale | −5,841 | $16.33 | $95,372 | 2,836,776 | D |
| Open-market sales · 5,841 sh · avg $16.33 · $95,372 | |||||||
Loading xslF345X05/ownership.xml…